In accordance with privacy legislation, Kedrion S.p.A., controller of the data collected through this website, hereby informs the user that this website does not use profiling cookies to send advertising messages in line with the preferences expressed when browsing the web. This website installs third party cookies. By continuing to browse, including by scrolling down and clicking on website elements, the user agrees to the company’s cookies policy.
For more information, also as regards the technical cookies used by the website and to object to the use of individual cookies, reference should be made to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
CORPORATE
Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®
The product is approved for post-exposure prophylaxis against rabies infection
read moreEVENTS
Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany
A crowded symposium dedicated to the SIPPET Study was held on July 9th
read moreEVENTS
Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017
Global campaign to improve early diagnosis and optimal treatments for PID
read more-
CORPORATE - 25-08-2017
Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®
The product is approved for post-exposure prophylaxis against rabies infection
read more -
EVENTS - 14-07-2017
Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany
A crowded symposium dedicated to the SIPPET Study was held on July 9th
read more -
EVENTS - 22-05-2017
Farmindustria roadshow is hosted by Kedrion
Innovation and Production of Value held on 19th May at our Bolognana production plant
read more -
EVENTS - 27-04-2017
Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017
Global campaign to improve early diagnosis and optimal treatments for PID
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 